MEDINET Co., Ltd. Reports Earnings Results for the Third Quarter Ended June 2021
August 11, 2021 at 11:30 am IST
Share
MEDINET Co., Ltd. reported earnings results for the third quarter ended June 2021. For the period, the company reported net sales of ¥512 million compared to ¥637 million a year ago. Operating loss was ¥792 million compared to ¥642 million a year ago. Loss was ¥548 million compared to ¥633 million a year ago. Basic loss per share was ¥3.21 compared to ¥4.90 per share a year ago.
MEDINET Co., Ltd. is a Japan-based company mainly engaged in cell processing industry and cellular medical products business. It operates through two business segments. The Cell Processing Industry segment mainly engages in comprehensive support services for immune cell therapy, related services including clinical use from companies, universities, research institutes, outsourcing of cell processing for clinical trials and operation of cell culture processing facilities. The Cellular Medical Products segment is mainly engaged in research and development for obtaining approval for manufacture and marketing of cellular medical products. It also provides comprehensive support services for immune cell therapy.
MEDINET CO., LTD. 
